|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute of Mental Health (NIMH) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001232 |
Purpose
The normal menstrual cycle is produced by a series of hormonal signals that starts with the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. The hypothalamus is located in the brain and is often referred to as the master gland. GnRH then acts on the pituitary gland and causes it to release two hormones, follicle stimulating hormone (FSH) and lutenizng hormone (LH). LH and FSH act on the ovary and cause it to release the hormones directly involved in menstruation, estrogen and progesterone.
The purpose of this research study is to evaluate the hypothalamic-pituitary-gonadal axis activity as measured by pituitary hormones, FSH and LH in response to intravenous doses of gonadotropin releasing hormone (GnRH) in menstrual cycle-related hormones.
| Condition |
|---|
|
Depressive Disorder Healthy Mental Disorders Mood Disorders |
| Study Type: | Observational |
| Official Title: | Pituitary Gonadotropin Response to GnRH Stimulation in Menstrual, Climacteric and, Menopause-Related Mood and Behavioral Disorders |
| Estimated Enrollment: | 140 |
| Study Start Date: | July 1988 |
| Estimated Study Completion Date: | June 2000 |
This protocol is designed to accompany clinical protocol #81-M-0126, "The Phenomenology and Biophysiology of Menstrually Regulated Mood and Behavior Disorders", as well as the submitted protocol, "The Phenomenology and Biophysiology of Climacteric and Menopause-Related Mood and Behavioral Disorders." Its purpose will be to evaluate hypothalamic-pituitary-gonadal axis regulation as measured by pituitary gonadotropin, i.e., follicle stimulating hormone (FSH) and luteinizing hormone (LH), response to intravenous administration of gonadotropin releasing hormone (GnRH) in menstrual cycle-related mood disorders.
Eligibility| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Age 18-65.
Female.
Use of barrier methods of birth control.
Not pregnant.
Not taking ongoing medications.
No medical illnesses.
Contacts and Locations More Information
| Study ID Numbers: | 880132, 88-M-0132 |
| Study First Received: | November 3, 1999 |
| Last Updated: | March 3, 2008 |
| ClinicalTrials.gov Identifier: | NCT00001232 History of Changes |
| Health Authority: | United States: Federal Government |
|
Depression FSH GnRH |
LH Menopause Menstrual Cycle |
|
Depression Disease Physiological Effects of Drugs Reproductive Control Agents Depressive Disorder Fertility Agents, Male Pharmacologic Actions Behavioral Symptoms |
Pathologic Processes Mental Disorders Therapeutic Uses Fertility Agents, Female Fertility Agents Mood Disorders Gonadotropins, Pituitary |
